alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Federal Register Volume 80, Number 77 (Wednesday, April 22, 2015)]
[Notices]
[Pages 22553-22554]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-09343]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]

Importer of Controlled Substances Application: Meridian Medical 
Technologies

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.34(a) on or before May 22, 2015. Such persons may also file a 
written request for a hearing on

[[Page 22554]]

the application pursuant to 21 CFR 1301.43 on or before May 22, 2015.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODXL, 
8701 Morrissette Drive, Springfield, Virginia 22152. Request for 
hearings should be sent to: Drug Enforcement Administration, Attention: 
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Deputy Assistant Administrator of the DEA Office of Diversion 
Control (``Deputy Assistant Administrator'') pursuant to section 7 of 
28 CFR part 0, appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on 
January 8, 2015, Meridian Medical Technologies, 2555 Hermelin Drive, 
St. Louis, Missouri 63144 applied to be registered as an importer of 
morphine (9300), a basic class of controlled substance listed in 
schedule II.
    The company manufactures a product containing morphine in the 
United States. The company exports this product to customers around the 
world. The company has been asked to ensure that its product, which is 
sold to European customers, meets the standards established by the 
European Pharmacopeia, administered by the Directorate for the Quality 
of Medicines (EDQM). In order to ensure that its product will meet 
European specifications, the company seeks to import morphine supplied 
by EDQM for use as reference standards.
    This is the sole purpose for which the company will be authorized 
by the DEA to import morphine.

    Dated: April 14, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-09343 Filed 4-21-15; 8:45 am]
 BILLING CODE 4410-09-P
```
### Transport Transports Canada Canada TP 7245E



# AIRWORTHINESS DIRECTIVE

The following airworthiness directive (AD) may be applicable to an aircraft which our records indicate is registered in your na me. ADs are issued pursuant to Canadian Aviation Regulation (CAR) 521 Division X . Pursuant to CAR 605.84 and the further details of CAR Standard 625, Appendix H , the continuing airworthiness of a Canadian registered aircraft is contingent upon compliance with all applicable ADs. Failure to comply with the requirements of an AD may invalidate the flight authorization of the aircraft. Alternative means of compliance shall be applied for in accordance with CAR 605.84 and the above-referenced Standard

. This AD has been issued b y the Continuin g Airworthiness Division ( AARDG ) , National Airc r aft Certification Branch, Trans p ort Canada, Ottawa, tele p hone 613 952-4357.

Pursuant to CAR 202.51 the registered owner of a Canadian aircraft shall, within seven days, notify the Minister in writing of any change of his or her name or address. To request a change of address, contact the Civil Aviation Communicat ions Centre (AARC) at Place de Ville, Ottawa, Ontario K1A 0N8 , or 1-800-305-2059 , or www.tc.gc.ca/civilaviation/communications/centre/ address.asp
2 4-0022 ( 01-2005 ) 

### 1/1 No

. 

### CF-2013-40 Issue Date 

### 9 December 2013

Number: CF-2013-40 Subject: Incorrect Installation of the Main Landing Gear Emergency Release Clevis Effective: 23 December 2013 Applicability: Bombardier Inc. model DHC-8- 400, -401 and -402 aeroplanes, serial numbers 4001 through 4109. Compliance: Within 2000 hours air time or 12 months , whichever occurs first, from the effective date of this AD. Background: A discrepancy has been found in the Main Landing Gear (MLG) emergency release clevis installation. During production, an incorre ct clevis was used, resulting in improper installation onto the MLG alternate release cable. Failure of the clevis could cause the loss of the alternate release system, preventing the MLG from extending in the case of a failure of the normal MLG extension/retraction system. This AD mandates the inspection for proper MLG emergency release clevis installation, and the rectification as required. Corrective Actions: Perform a detailed visual inspection of the MLG emergency release clevis installation, and rectify as required, in accordance wi th the Accomplishment Instructions of Bombardier Service Bulletin 84-32-67, Initial Issue, dated 8 July 2009, or later revisions approved by the Chief, Continuing Airworthiness, Transport Canada. Authorization: For the Minister of Transport, ORIGINAL SIGNED BY Robin Lau Acting Chief, Continuing Airworthiness Contact: Anthony Wan, Continuing Airworthine ss, Ottawa, telephone 613-952-4357, facsimile 613-996-9178 or e-mail AD-CN@tc.gc.ca or any Transport Canada Centre.
UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C.  20549





FORM 8-K





CURRENT REPORT


PURSUANT TO SECTION 13 OR 15(D) OF


THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported):  June 26, 2012


EMRISE CORPORATION


(Exact name of registrant as specified in its charter)





Delaware001-1034677-0226211(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)2530 Meridian Parkway, Durham, NC27713(Address of principal executive offices)(Zip Code)


(408) 200-3040


(Registrant’s telephone number, including area code)


Not Applicable


(Former name or former address, if changed since last report.)





---










Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2.):


[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




---

Item 7.01    Regulation FD Disclosure





Beginning June 27, 2012, EMRISE Corporation’s Chief Executive Officer, Carmine T. Oliva, will present a power point presentation at various meetings with both current shareholders and prospective investors (the “Presentation”).  A copy of the Presentation is filed as Exhibit 99.1 to this Current Report on Form 8-K.





The Presentation shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that Section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.





Item 9.01    Financial Statements and Exhibits.


(d) Exhibits.





Exhibit No.  Description


|     |                                    
|---- | -----------------------------------
|99.1 | Power Point Investor Presentation.*




* Filed herewith.





---




SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.





Date:  June 26, 2012EMRISE CORPORATIONBy:/s/ Carmine T. OlivaCarmine T. OlivaChief Executive Officer











---




EXHIBIT INDEX





Exhibit No.  Description





|     |                                    
|---- | -----------------------------------
|99.1 | Power Point Investor Presentation.*




* Filed herewith.
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-392]
 ACTION: Notice of application.
 DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before June 22, 2015.
 ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA 
                        **Federal Register**
                         Representative/ODXL, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (“Deputy Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on February 10, 2015, Stepan Company, Natural Products Department, 100 W. Hunter Avenue, Maywood, New Jersey 07607 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance
ScheduleCocaine (9041)
IIEcgonine (9180)
II
 The company plans to manufacture the listed controlled substances in bulk for distribution to its customer. Dated: April 14, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator.


[FR Doc. 2015-09327 Filed 4-21-15; 8:45 am] BILLING CODE 4410-09-P
Exhibit 35.1

Servicer Compliance Statement of AmeriCredit Financial Services, Inc.

This Annual Statement as to Compliance is delivered to you pursuant to Section 2.9 (c) of the 2015-1 Servicing Supplement dated as of
February 1, 2015 (the Agreement) and Item 1123 of Regulation AB, executed in connection with the formation of GM Financial Automobile Leasing Trust 2015-1 (the Trust), the issuance of the Notes by the Trust and the
closing of the transactions and the execution and delivery of the various documents by AmeriCredit Financial Services, Inc. (the Servicer) and GMF Leasing LLC in connection therewith. The capitalized terms used herein shall have the same
meanings as in the Agreement.

The undersigned certifies that I am the Executive Vice President, Corporate Controller and Chief Accounting
Officer of the Servicer. I further certify as follows:



| | 1. | I have conducted, or caused to be conducted under my supervision, a review of the Servicer during the preceding period from February 1, 2015 through December 31, 2015, and its performance under the Agreement.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | To the best of my knowledge, following such review, the Servicer has fulfilled all its obligations under the Agreement throughout such period, and, to the best of my knowledge, there has been no default in the
fulfillment of any such obligation.
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AmeriCredit Financial Services, Inc.



|    |  |                                         |  |  |  |                      
|--- |  | --------------------------------------- |  |  |  | ---------------------
|By: |  | /s/ Connie Coffey                       |  |  |  | Dated: March 25, 2016
|    |  | Connie Coffey                           |  |  |  |                      
|    |  | Executive Vice President, Corporate     |  |  |  |                      
|    |  | Controller and Chief Accounting Officer |  |  |  |
**Exhibit**** 32**

 

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER ANDCHIEF FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF2002**

 

I, Shaw Hong, certify, pursuant to 18 U.S.C.Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that the Quarterly Report of OmniVisionTechnologies, Inc. on Form 10-Q for the quarter ended October 31,2007 fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934 and that information contained in suchQuarterly Report on Form 10-Q fairly presents in all material respects thefinancial condition and results of operations of OmniVision Technologies, Inc.A signed original of this written statement required by Section 906 hasbeen provided to OmniVision Technologies, Inc. and will be retained byOmniVision Technologies, Inc. and furnished to the Securities and ExchangeCommission or its staff upon request.

 

 

Dated: December 10, 2007

 

 
| ** ** | By:                                               | **/s/ SHAW HONG** |
|------------|---------------------------------------------------|-------------------|
|       | **Shaw Hong**                                     |
|       | *Chief Executive Officer, President and Director* |
|       | *(Principal Executive Officer)*                   |

 

 

I, Peter V. Leigh, certify, pursuant to 18 U.S.C.Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that the Quarterly Report of OmniVisionTechnologies, Inc. on Form 10-Q for the quarter ended October 31,2007 fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934 and that information contained in suchQuarterly Report on Form 10-Q fairly presents in all material respects thefinancial condition and results of operations of OmniVision Technologies, Inc.A signed original of this written statement required by Section 906 hasbeen provided to OmniVision Technologies, Inc. and will be retained byOmniVision Technologies, Inc. and furnished to the Securities and ExchangeCommission or its staff upon request.

 

 

Dated: December 10, 2007

 

** **
|   | By:                                            | **/s/ PETER V. LEIGH** |
|--------|------------------------------------------------|------------------------|
|   | **Peter V. Leigh**                             |
|   | *Chief Financial Officer*                      |
|   | *(Principal Financial and Accounting Officer)* |

 

----
IN THE DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FIFTH DISTRICT

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

DYCK

- O'NEAL, INC.

,

Appellant

,

v. Case No. 5D 17

- 1059

ROBERT GERMANY AND LINDA K.

PLANT

- GERMANY

,

Appellee s

.

________________________________/

Opinion filed February 2 3

, 2018

Appeal from the Circuit Court

for P utnam County

, Scott C. Dupont , Judge.

David M. Snyder, of David M Snyder, PA, Tampa, Susan B. Morrison, of Law Offices of Susan B. Morrison, P.A., Tampa, and Joshua D. Moore, of Law Offices of Daniel C. Consuegra, Tampa, for Appellant.

Douglas N. Burne tt, and M. Aaron Dukes, St. Johns Law Group, St. Augustine, for Appellee Linda K. Carroll.

No appearance for other Appellee.

EDWARDS , J.

Dyck

- O’Neal, Inc. (“DONI”) appeals the summary judgment granted in favor of

Appellee

, Linda Carroll f/k/a Linda K. Plant

- Germany. DONI correctly argues that the trial2

court erred in f inding DONI’s action time

- barred. See Chrestensen v. Eurogest, Inc. , 906

So. 2d 343, 344 (Fla. 4th DCA 2005) (holding that the statute of limitations to seek a

deficiency judgment does not begin to run until after the entry of foreclosure judgment

and subsequent foreclosure sale). We also decline Appellee’s suggestion that we affirm

the final summary judgment based on a ground that she did not raise below. See Trainor

v. PNC Bank, Nat ’l Ass’n , 211 So. 3d 366, 368 (Fla. 5th DCA 2017). 1

Therefore, w e reverse the summary judgment entered in favor of Appellee and

remand for further proceedings consistent with this opinion. We also deny Appellee’s

motion for attorney’s fees.

REVERSED AND REMANDED.

PALMER and LAMBERT , JJ., concur.

1 Kinney v. Countrywide Home Lo an s Servicing, L .P.

, 165 So. 3d 691 (Fla. 2015)

, is inapplicable to this case; thus, Appellee should not have offered it as a legal basis for summary judgment, and the trial court erred in relying upon it.
UNITED STATES DISTRICT COURT
SOUTHERN DISTRICT OF OHIO
WESTERN DIVISION AT DAYTON

CARLETTA WILSON, : Case No. 3:17-cv-289
Plaintiff, : District Judge Walter H. Rice
: Magistrate Judge Sharon L. Ovington

vs.

COMMISSIONER OF THE SOCIAL
SECURITY ADMINISTRATION,

Defendant.

DECISION AND ENTRY

This case is before the Court on the parties’ Joint Motion for an Award of
Attorney’s Fees Pursuant to the Equal Access to Justice Act (“EAJA”), 28 U.S.C. §
2412. (Doc. #17). Specifically, the parties stipulate and petition this Court under the
EAJA to enter an order awarding Plaintiff $5,700.00 (five thousand seven hundred
dollars) in attorney fees, costs, and expenses. The award of attorney fees, costs, and
expenses will fully satisfy and settle any and all of Plaintiff's claims under 28 U.S.C. §
2412 that may be payable in this case. Any fees paid belong to Plaintiff and can be
offset to satisfy any pre-existing debt that Plaintiff owes the United States, pursuant to
the decision in Astrue v. Ratliff, 560 U.S. 586, 130 S.Ct. 2521 (2010).

After the Court enters this award, if counsel for the parties can verify that
Plaintiff owes no pre-existing debt subject to offset, Defendant agrees to direct that the

award be made payable to Plaintiff's attorney pursuant to an EAJA assignment duly


signed by Plaintiff.
IT IS THEREFORE ORDERED THAT:

1. The Parties’ Joint Motion for an Award of Attorney’s Fees
Pursuant to the Equal Access to Justice Act (Doc. #17) is
accepted and the Commissioner shall pay Plaintiff's attorney
fees, costs, and expenses in the total amount of $5,700.00;

2s Counsel for the parties shall verify, within thirty days of this
Decision and Entry, whether or not Plaintiff owes a pre-
existing debt to the United States subject to offset. If no such
pre-existing debt exists, Defendant shall pay the EAJA award
directly to Plaintiff's counsel pursuant to the EAJA assignment
signed by Plaintiff; and

35 The case remains terminated on the docket of this Court.
IT IS SO ORDERED.
Date: 8-19-19 l Smee.

Walter H. Rice
United States District Judge
Exhibit 23 -- Consent of Experts


G. BRAD BECKSTEAD
---------------------------
Certified Public Accountant

                                                       330 E. Warm Springs
                                                      Las Vegas, NV  89119
                                                              702.528.1984
                                                       425.928.2877 (efax)



October 18, 2001


To Whom It May Concern:

The firm of G. Brad Beckstead, CPA, consents to the inclusion of my report
of October 18, 2001, on the Financial Statements of Business Translation
Services, Inc. for the periods ended September 30, 2001 and December 31,
2000, in any filings which are necessary now or in the near future to be
filed with the US Securities and Exchange Commission.

Signed,

/s/ G. Brad Beckstead
------------------------------
G. Brad Beckstead, CPA



<PAGE>
Exhibit 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of Star Gas Partners, L.P. (the Partnership) and Star Gas Finance Company on Form 10-K for the year ended September 30, 2005 as filed with the Securities and Exchange Commission on the
date hereof (the Report), I, Joseph P. Cavanaugh, Chief Executive Officer of the Partnership and Star Gas Finance Company, certify to my knowledge pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, following due inquiry, I believe that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Partnership and Star Gas Finance Company.
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



A signed original of this written statement required by
Section 906 has been provided to Star Gas Partners, L.P. and will be retained by Star Gas Partners, L.P. and furnished to the Securities and Exchange Commission or its staff upon request.



|                  |  |                                                                                     |  |                                                                                             
|----------------- |  | ----------------------------------------------------------------------------------- |  | --------------------------------------------------------------------------------------------
|                  |  | STAR GAS PARTNERS, L.P. STAR GAS FINANCE
COMPANY By: STAR GAS LLC (General Partner)
|                  |  |                                                                                    
|December 12, 2005 |  | By:                                                                                 |  | /s/ Joseph P. Cavanaugh                                                                     
|                  |  |                                                                                     |  | Joseph P. Cavanaugh Chief Executive
Officer Star Gas Partners, L.P. Star Gas Finance
Company